GenMark Diagnostics (GNMK) – Event News
-
Roche to acquire GenMark Diagnostics (GNMK) for $24.05/Share
-
Canaccord Genuity Sees GenMark Diagnostics (GNMK) Trading Above Buyout Comps, PT Raised to $24
-
-
-
-
-
-
-
Back to GNMK Stock Lookup